KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.82 $19.54 Friday, 26th Apr 2024 MGNX stock ended at $14.56. This is 1.32% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 7.31% from a day low at $14.22 to a day high of $15.26.
90 days $12.82 $21.88
52 weeks $4.29 $21.88

Historical MacroGenics prices

Date Open High Low Close Volume
Jan 09, 2024 $10.44 $10.56 $10.10 $10.20 445 720
Jan 08, 2024 $9.72 $10.60 $9.55 $10.51 1 394 932
Jan 05, 2024 $9.89 $9.89 $9.45 $9.77 342 971
Jan 04, 2024 $10.04 $10.26 $9.86 $10.05 337 404
Jan 03, 2024 $10.11 $10.33 $9.90 $9.96 410 230
Jan 02, 2024 $9.51 $10.20 $9.33 $10.18 683 884
Dec 29, 2023 $10.00 $10.02 $9.61 $9.62 271 049
Dec 28, 2023 $9.88 $10.10 $9.77 $9.94 272 314
Dec 27, 2023 $10.23 $10.24 $9.80 $9.96 310 397
Dec 26, 2023 $9.93 $10.28 $9.80 $10.11 442 818
Dec 22, 2023 $9.99 $10.22 $9.62 $9.87 484 612
Dec 21, 2023 $10.06 $10.25 $9.78 $10.00 590 171
Dec 20, 2023 $10.08 $10.74 $9.82 $9.83 1 453 292
Dec 19, 2023 $8.81 $9.32 $8.81 $9.23 593 734
Dec 18, 2023 $9.24 $9.24 $8.63 $8.68 498 506
Dec 15, 2023 $9.45 $9.64 $9.15 $9.26 2 070 246
Dec 14, 2023 $9.30 $9.44 $9.10 $9.31 619 417
Dec 13, 2023 $8.60 $9.19 $8.60 $9.17 561 184
Dec 12, 2023 $8.48 $8.70 $8.38 $8.66 596 716
Dec 11, 2023 $8.85 $8.85 $8.37 $8.46 447 948
Dec 08, 2023 $8.84 $9.10 $8.66 $8.71 368 420
Dec 07, 2023 $8.70 $9.00 $8.53 $8.93 433 964
Dec 06, 2023 $8.62 $8.80 $8.51 $8.64 369 596
Dec 05, 2023 $8.38 $8.60 $8.30 $8.48 467 059
Dec 04, 2023 $8.47 $8.65 $8.21 $8.45 446 305
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT